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Pre-operative anaemia and the need for intra-operative transfusion have been 
associated with increased morbidity and mortality following cardiac and major non-
cardiac surgery. Anaemia is highly prevalent in patients with severe chronic liver 
disease. Whether this correlates with an altered morbidity and mortality following 
liver transplant has not been established.  
Methods 
Prospectively collected data was analysed for the period 1998-2012. Donor and 
recipient characteristics, blood profiles and complications were recorded. Graft and 
patient survival was calculated. All patients were followed up for 1 year or until 
death. Pre-operative haemoglobin levels were correlated with patient demographics 
and outcome using a binary logistic regression analysis. 
Results 
Pre-operative anaemia, according to WHO criteria, occurred in 73% of patients. 
Anaemia was more common with advanced liver disease (higher MELD score). As 
MELD score increased, Haemoglobin levels dropped. Anaemic patients were more 
commonly transfused (p<0.001), spent longer ventilated (7 day vs 5 days, p=0.005) 
and required longer ITU stays (8 days vs 6 days, p = 0.015). Pre-operative anaemia 
did not correlate with patient morbidity or mortality. 
Conclusions: 
Reduced haemoglobin levels reflect the severity of chronic liver disease but are not an 
independent risk factor for a poor outcome following liver transplantation. 
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Introduction: 
Liver transplantation is the only effective treatment available to patients with end 
stage chronic liver failure. Liver transplantation is highly effective but is a major 
surgical procedure with a 1 year mortality rate of 14% (1). Reducing the post-
operative mortality rate is a major goal in liver transplant surgery. 
Anaemia is a common finding in surgical patients occurring in approximately 30.4% 
of patients undergoing non-cardiac surgery (2). Pre-operative anaemia has been 
identified as an independent risk factor for post-operative morbidity and mortality in 
several surgical fields (2)(3)(4)(5). In the setting of cardiac surgery, a haemoglobin 
level of less than 12mg/dL has been shown to increase the risk of surgical mortality 
three fold and the incidence of significant post-operative morbidity five fold (6). The 
mechanism linking anaemia with poor outcome is unknown. Reduced tissue 
oxygenation, increased haemodilution and increased incidence of transfusion have 
been implicated as possible mechanisms of a reduced physiological ability to cope 
with the stress of major surgery (6).  
Anaemia is common in patients with advanced chronic liver disease. 75% of patients 
undergoing treatment for hepatitis C virus are anaemic (7). The pathology of anaemia 
in severe liver disease is diverse including acute and chronic blood loss into the GI 
tract, malnutrition, haemolysis and treatment of viral hepatitis (8)(9). As the 
underlying pathophysiology of the liver disease is so variable in this group of patients, 
the underlying type of anaemia in patients with chronic liver disease may similarly 
vary from iron deficiency to Vitamin B12 and folate deficiency (8)(10) making 
correction of anaemia difficult. Correction of haemoglobin levels in patients with 
Hepatitis C can be achieved with Erethropoetin (7). 
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With the current median waiting time between being listed for transplantation to 
undergoing transplantation being 4-5 months in the UK (11), there is ample time to 
correct pre-operative anaemia prior to transplantation.  
Although anaemia has been investigated as a predictor of the need for intra-operative 
transfusions in liver transplantation (12)(13), the significance of pre-operative 
anaemia to the early outcomes of liver transplant surgery has not been established and 
was the aim of this study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
4 
Methods: 
A prospectively collected liver transplant database was reviewed between the years of 
1998 and 2012 to allow significant sample size and adequate follow up data. All 
donor types (DBD, DCD, split and domino grafts) were included in the analysis. Re-
transplantations were also included. 
Haemoglobin levels were measured in peripheral venous blood (Sysmex XE-2100, 
Sysmex Corporation, Milton Keynes, UK) on the day of admission for liver transplant 
along with full biochemistry profiles including a Model for End-Stage Liver Disease 
(MELD) score. 
 
Transplant procedure: 
Grafts were identified and retrieved through NHS blood and transplant (NHSBT) by 
the designated regional teams within the UK National Organ Retrieval Service 
(NORS). All grafts were retrieved according to the national standards for organ 
retrieval from deceased donors (NHSBT) (14). Grafts were routinely perfused in situ 
with cold University of Wisconsin (UW) solution (Organ Recovery Systems, 
Chicago). 
Both piggy-back and caval replacement techniques for liver transplantation were 
utilised. Veno-venous bypass was not routinely employed.  
1 mg of methylprednisolone (Pharmacia) was given intravenously during the 
anhepatic phase. All patients were monitored via invasive central and venous blood 
pressures. 
Post operative management: 
Post-operatively all patients were managed in the intensive care unit. 
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Haemoglobin levels were maintained below 10g/L to reduce the risk of graft 
thrombosis. 
Platelets and fresh frozen plasma were administered only if there was active bleeding 
associated with a coagulopathy or thrombocytopaenia. Patients were routinely started 
on subcutaneous thromboprophylaxis on the first post-operative day. 
All patients underwent a Doppler ultrasound scan of the liver vessels on the first, third 
and fifth post-operative day and underwent routine daily bloods including liver 
function tests. 
Patients were extubated on the first post-operative day unless there was a clinical need 
for ongoing respiratory support. 
Standard immunosuppression therapy was commenced on day one post-operatively. 
 
Pre-operative anaemia: 
Haemogloblin levels were documented on the day of admission for liver transplant 
and patients were classified as anaemic according to the World Health Organisation 
(WHO) definition of male <13g/dL or female <12g/dL (15). The need for intra-
operative Red Cell Concentrate (RCC) transfusion was determined by the anaesthetic 
team and was based on blood loss, systemic haemodynamics and haemoglobin level 
on routine arterial blood gas analysis. Clotting factor replacement was based on blood 
loss and near patient coagulation monitoring using Thromboelastography (TEG) 
readings. 
 
Mortality: 
Patient mortality was defined as death from any cause and was calculated at 30 days, 
90 days and at 1 year post transplantation. 
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Morbidity: 
Post-operative morbidity included, graft loss within 3 months, the need for organ 
support (respiratory and renal), biliary complication (leak and stricture), hepatic artery 
thrombosis (HAT), portal vein thrombosis (PVT) and post-operative infective 
episodes (bacterial/fungal/viral). Infective complications were only included when a 
positive culture was documented. 
 
Donor, transplant and recipient factors: 
When regression models were performed, pre-operative haemoglobin was adjusted 
for the donor variable age, the transplant variables - length of cold ischaemic time and 
length of vascular anastomosis time and the recipient variables - age, gender and pre-
operative MELD score. 
 
MELD score and its relationship with haemoglobin: 
To further explore the relationship between pre-operative haemoglobin levels and 
MELD score, MELD was broken down into the individual components that are used 
to calculate it – serum creatinine, serum bilirubin and INR (16). Data regarding recent 
dialysis in the last week was missing and as such the UNOS modification of altering 
creatinine accordingly was not used. 
 
Statistical analysis: 
Results were analysed on the Statistical Package for the Social Sciences (SPSS) 
version 21, IBM. Univariate comparisons between anaemic and non-anaemic groups 
were performed using chi-squared tests for dichotomous variables and independent 
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samples t-tests for continuous variables for parametic data and Mann-Whitney U tests 
for non-parametric data.  
A binary logistic regression model was used to adjust haemoglobin values for donor, 
transplant and recipient factors when the outcome measured was dichotomous and a 
linear regression model was used when the outcome was a continuous variable.  
A spearman’s bivariate correlation was used to correlate haemoglobin values with 
individual components of MELD score. 
A p value of <0.05 was considered to be significant. 
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Results 
Data was analysed on 795 patients (416 Female/377 Male/1 Unknown) undergoing 
liver transplant between 1998 and 2012. Minimum follow up was 30 days or until 
death, maximum follow up was 1 year. The median donor age was 43 (31-53). The 
majority of grafts were from donors after brain death (DBD) (97%). The median cold 
ischaemic time was 604 mins (454-744). 99.6% of grafts were preserved in 
commercial University of Wisconsin preservation fluid (Organ Recovery Systems, 
Chicago). Further donor and transplant variables are described in Table 1. The median 
recipient age at time of transplantation was 50 years (41-57) and the median pre-
operative MELD score was 16 (12-22) Further recipient characteristics are given in 
Table 2. The main indications for transplantation were hepatitis C virus (HCV) related 
cirrhosis (23%) and alcoholic liver disease (ALD) (18%). Other indications are given 
in Table 3. 
Median pre-operative haemoglobin level was 11 mg/dL (9.6-12.5). 
100 patients (7.8%) died within 30 days of their transplant, 141 patients (11.1%) died 
within 90 days of their transplant and 218 patients (17.9%) died within 1 year of their 
transplant. 
 
Incidence of pre-operative anaemia: 
When calculated according to WHO classification (15), 580 patients (73%) were 
anaemic on the day of admission for liver transplantation. Anaemia was prevalent 
across all indications for transplantation ranging from 44-100% (Table 2). Anaemic 
patients were younger [50(40-57) vs 51(44-58), p=0.026], were more likely to be 
female, had more advanced liver disease as measured by MELD score [17(13-24) vs 
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13(9-17), p<0.001] and poorer pre-operative renal function as measured by creatinine 
levels (p<0.001) (Table 4). 
 
Pre-operative anaemia and post transplant outcomes: 
On univariate analysis, anaemia did not correlate with 30 day (p=0.305), 90 day 
(p=0.170), or 1 year mortality (p=0.162). As the majority (73%) of patients were 
classified as anaemic, haemoglobin was further explored as a continuous variable. 
Patients who died within 30 days had a significantly lower median pre-operative 
haemoglobin levels than patients that survived [10.6(9.1-11.6)g/dL vs 11.2(9.6-
12.5)g/dL, p=0.004]. This significance was continued at 90 days [10.6(9.4-12.1)g/dL 
vs 11.2(9.6-12.5)g/dL, p=0.015] and at 1 year [10.7(9.6-12.3)g/dL vs 11.2(9.7-
12.5)g/dL, p=0.021]. 
 
The presence of pre-operative anaemia was associated with a increased incidence of 
blood transfusion (P<0.001) and median number of units transfused (5 vs 2, p<0.001), 
an increased stay in ITU (p=0.015) and an increased need for respiratory support 
(p=0.005) but was not associated with an increased risk of post-operative 
complication rates including graft loss at 3 months (Table 5). 
 
A binary logistic regression analysis was performed to analyse whether pre-operative 
haemoglobin levels were an independent risk factor for post-operative mortality when 
adjusted for other donor, transplant and recipient variables. Pre-operative 
haemoglobin levels correlated with increased 1 year mortality (p=0.046) but not with 
mortality at 30 days (p=0.277) or 90 days (p=0.124) (Table 6). 
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Pre-operative haemoglobin levels were inversely correlated with MELD scores 
(p<0.001). As the MELD score increased (Figure 1), the pre-operative haemoglobin 
level was lower by 0.398g/dL/unit MELD score. When MELD scores were excluded 
from the regression analysis, pre-operative haemoglobin levels correlated 
significantly with mortality at all time points (p=0.028, p=0.010, p=0.001) (Table 7). 
 
To explore which individual factors of the MELD score influenced haemoglobin 
levels, a linear regression analysis was performed including pre-operative INR, 
bilirubin and creatinine levels. Pre-operative creatinine levels (p<0.001), INR 
(p<0.001) and bilirubin levels (p=0.007) were each significantly correlated with pre-
operative haemoglobin levels. For every increase in pre-operative creatine levels, 
serum haemoglobin levels dropped by 0.298g/dL/micromol/L creatinine while for 
every increase in bilirubin levels, serum haemoglobin levels dropped by 
0.311g/dL/micromol/L bilirubin and for every increase in INR, haemoglobin levels 
dropped by 0.345g/dL/unit INR. 
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Discussion: 
This study is the first to analyse the role of pre-operative anaemia as a risk factor for 
mortality and the development of post-operative complications in liver transplant 
surgery. It has shown that pre-operative anaemia, as defined by the WHO 
classification, is not an independent risk factor for early post-operative mortality or 
the development of post-operative complications in this large cohort of patients 
undergoing liver transplantation. Anaemic patients are significantly more likely to 
require a blood transfusion and spend longer in ITU. 
 
The incidence of anaemia, according to the WHO definition (15), in patients 
undergoing liver transplantation was high at 73%. This is in keeping with other 
studies of anaemia in patients with end stage liver disease (7). The aetiology of 
anaemia in chronic liver disease is diverse; folate and vitamin B12 deficiency, 
hypersplenism, haemodilution, bone marrow suppression caused by ethanol or 
viruses, autoimmune haemolysis, renal insufficiency and variceal bleeding may all 
contribute (17). Anaemia is postulated to increase bleeding risk through reduced 
platelet activation and aggregation, and worsening the hyperdynamic circulation(18). 
 
Our analysis suggests the anaemia is secondary to the severity of the chronic liver 
disease. We recorded a strong correlation between pre-operative haemoglobin level 
and MELD score. MELD is multifactorial and is calculated based on a patient’s INR, 
serum creatinine and bilirubin levels (16). To help identify the association between 
pre-operative haemoglobin levels and MELD score an analysis of individual factors 
of the MELD score and haemoglobin values was performed. This identified that both 
hepatic and renal dysfunction were associated with reduced haemoglobin levels. 
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These findings are important for two reasons.  Anaemia is strongly associated with 
renal dysfunction (19) and can be successfully treated with erythropoietin (EPO) 
(19)(20). A previous study investigating anaemia in patients under treatment for 
advanced Hepatitis C demonstrated that anaemic patients, with advanced liver 
disease, could be successfully treated with daily EPO injections (21). During the 
period of a patient waiting for a liver transplant, underlying low haemoglobin values 
could be corrected reducing the need for intra-operative transfusions and potentially 
improving outcome. 
 
The major limitation of this study is that, along with the majority of other studies on 
pre-operative anaemia, it does not identify the underlying mechanism of the increased 
risk of post-operative mortality but suggests it may be secondary to severity of liver 
disease. Although it may be possible to correct low haemoglobin levels pre-
operatively, if the mechanism of increased risk of post-operative mortality is 
secondary to more advanced liver disease, it will not lead to decreased mortality 
levels post-operatively.  
 
Correction of pre-operative anaemia may reduce the need for blood transfusion in this 
group of patients and may lead to a reduced requirement for intensive care support 
which would represent a cost saving for the health service. A full economic costing of 
the effect of correcting pre-operative haemoglobin levels would therefore be 
warranted. 
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Table 1: Median donor and transplant characteristics (interquartile range) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Age 43 (31-53) 
Type of Donor Deceased brain death 752 
Deceased cardiac death 33 
Domino 8 
Split 3 
Length of time in ITU 3 (2-5) 
Cold ischaemic time (minutes) 604 (454-744) 
Implantation warm ischaemic time (minutes) 43 (37-49) 
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Table 2: Median recipient characteristics (interquartile range) 
Gender Male 377 
Female 416 
Age 50 (41-57) 
Pre operative MELD score 16 (12-22) 
Pre-operative creatinine (micromoles/L) 90 (75-116) 
Preoperative haemoglobin (g/dL) 11.0 (9.6-12.5) 
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Table 3: Indication for transplantation 
Indication for transplantation number Percentage anaemic 
Hepatitis C Cirrhosis 182 67.6% 
Alcohol Liver Disease 145 76.7% 
Primary Biliary Cirrhosis 82 65.9% 
Primary Sclerosing 
Cholangitis 
61 82.0% 
Acute Liver Failure (unknown 
cause) 
60 66.7% 
Hepatitis B Cirrhosis 57 59.6% 
Cryptogenic Cirrhosis 39 76.9% 
Auto-immune Hepatitis 23 65.2% 
Hepato-cellular Carcinoma 
(Cirrhosis) 
20 55.0% 
Hepatic Artery Thrombosis 20 95.0% 
Other 19 89.5%% 
Acute Liver Failure 
(paracetamol) 
14 100% 
Metabolic Diseases 12 75.0% 
Primary Graft Non-Function 11 100% 
Familial Adenomatous 
Polyposis 
9 44.4% 
Biliary Complication 8 75.0% 
Chronic Rejection 7 85.7% 
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Other 4 50.0% 
Budd Chiari Syndrome 4 50.0% 
Wilson’s Disease 3 100% 
Ductopenic Rejection 3 100% 
Other Malignancy 3 66.7% 
Non-Thrombotic Infarction 2 100% 
Hepato-Cellular Carcinoma 
(non-cirrhtoic) 
2 50.0% 
Polycystic Disease 1 100% 
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Table 4: Recipient pre-operative characteristic and their association with pre-
operative anaemia 
 
No pre-operative anaemia 
(n=215) 
Pre operative anaemia 
(n=580) 
P value 
Gender   0.004 
Male 83 294  
Female 130 286  
Recipient age 51 (44-58) 50 (40-57) 0.026 
MELD score 13 (9-17) 17 (13-24) <0.001 
Creatinine level 
(micromoles/L) 
92 (75-118) 89 (75-115) <0.001 
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Table 5: Univariate analysis of anaemia and the incidence of post operative morbidity 
and mortality 
Outcome measure 
No pre operative 
anaemia (n=215) 
Pre-operative 
anaemia (n=580) 
P value 
30 day mortality 9 (4%) 37 (6%) 0.305 
90 day mortality 11 (5%) 48 (8%) 0.17 
1 year mortality 18 (9%) 50 (9%) 0.162 
3 month graft loss 20 (9%) 69 (12%) 0.375 
Need for RRT 27 (13%) 100 (17%) 0.127 
ITU days 5.88 8.45 0.015 
Ventilated days 4.51 7.07 0.005 
Bacteraemias 9 (4%) 28 (5%) 0.850 
Fungal infection 2 (1%) 9 (1%) 1.00 
Viral infection 4 (2%) 8 (1%) 0.744 
Hepatic Artery Thrombosis 7 (3%) 29 (5%) 0.342 
Portal Vein Thrombosis 0 (0%) 3 (1%) 0.567 
Biliary stricture 4 (2%) 18 (3%) 0.467 
Bile leak 13 (6%) 42 (7%) 0.638 
Need for intra op transfusion 120 (56%) 510 (88%) <0.001 
Median units transfused 2 5 <0.001 
  
 
 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
Table 6: Binary logistic regression analysis when MELD is included in the analysis. 
Variable 
30 day mortality 
(p values) 
90 day mortality 
(p values) 
1 year mortality 
(p values) 
MELD 0.002 0.011 0.003 
Pre-operative haemoglobin 0.277 0.124 0.046 
Recipient gender 0.123 0.062 0.030 
Recipient age 0.377 0.640 0.057 
Donor age 0.527 0.164 0.119 
Donor type 0.996 0.996 0.883 
Cold ischaemic time 0.235 0.118 0.284 
Vascular anastomosis time 0.180 0.123 0.178 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Table 7: Binary logistic regression analysis showing pre-operative haemoglobin levels 
correlate with post-operative mortality when MELD is not included in the analysis. 
Variable 
30 day mortality 
(p values) 
90 day mortality 
(p values) 
1 year mortality 
(p values) 
Pre-operative haemoglobin 0.028 0.010 0.001 
Recipient gender 0.122 0.047 0.023 
Recipient age 0.948 0.891 0.222 
Donor age 0.597 0.231 0.174 
Donor type 0.996 0.298 0.907 
Cold ischaemic time 0.160 0.106 0.237 
Vascular anastomosis time 0.210 0.154 0.221 
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Figure 1: Median haemoglobin values grouped by MELD scores: 
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Highlights: 
• Anaemia is highly prevalent in patients undergoing liver transplant (73%) 
• Unlike in other major surgery, anaemia is not associated with an increased risk 
of mortality post liver transplant. 
• Haemoglobin levels are inversely correlated with MELD scores. 
• When MELD scores are removed from the analysis, low haemogloblin levels 
are associated with higher mortality suggesting that anaemia may reflect 
worse pre-operative burden of disease. 
